COMP <GO>
BGMS vs ALZN // RETURN ON INVESTED CAPITAL (ROIC)
Bio Green Med Solution Inc. (NASDAQ) VS. Alzamend Neuro Inc. (NASDAQ) • 15-METRIC TALLY: BGMS 3
— ALZN 0
■ METRIC PARITY
LAST: $0.90 (0.00%) • MKT CAP: $6.0M
roic
-35.00%
LAST: $1.25 (+3.31%) • MKT CAP: $5.8M
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BGMS VS. ALZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BGMS | ALZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 1/9 | +1.00 | BGMS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.6 | 38.2 | +11.40 | BGMS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.0M | $5.8M | $121.4K | BGMS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BGMS REV | ALZN REV | BGMS GROSS % | ALZN GROSS % | BGMS FCF | ALZN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $23.6M | $24.5M | — | — | -$4.8M | -$8.1M |
| FY 2024 | $43.0K | $12.6M | — | — | -$8.0M | -$6.6M |
| FY 2023 | $71.3M | $27.8M | — | — | -$16.1M | -$8.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BGMS // BETA —
ALZN // BETA —